{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:52:02Z","timestamp":1791377522161,"version":"4.3.2"},"reference-count":101,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Major depressive disorder (MDD) and treatment\u2010resistant depression (TRD) remain leading causes of disability, providing the impetus for receptor\u2010level treatment strategies beyond monoamine reuptake. The serotonin 5\u2010HT2B receptor (5\u2010HT2BR) is uniquely positioned at the interface of central\u2010antidepressant mechanisms and peripheral cardiac risks. Herein, we reviewed preclinical, translational and clinical literature identified via PubMed and OVID (MEDLINE, Embase, AMED, PsychINFO) databases from inception to September 2025, supplemented by manual searches. Evidence converges that peripheral 5\u2010HT2BR agonism is mechanistically linked to valvular heart disease (VHD) through mitogenic\/profibrotic signaling in valve tissue, consistent with historical signals for anorectic agents (e.g., fenfluramine) and ergot\u2010derived dopamine agonists, with supportive but limited data for 3,4\u2010methylenedioxymethamphetamine (MDMA). Classical serotonergic psychedelics bind 5\u2010HT2BRs; therefore, while contemporary dosing regimens are intermittent, cumulative exposure risks remain insufficiently characterized. Conversely, central 5\u2010HT2BR signaling appears bidirectional wherein astrocytic 5\u2010HT2BR activation under sustained serotonergic tone may support metabolic and plasticity programs, whereas neuronal 5\u2010T2BR antagonism can normalize mesolimbic dopamine output and enhance medial prefrontal glutamatergic activity. Clinically, several approved antidepressant adjuncts (e.g., aripiprazole, brexpiprazole, cariprazine) display 5\u2010HT2BR antagonism or inverse agonism and improve depressive symptoms without observed valvular signals in trials. The 5\u2010HT2BR represents a tractable augmentation target for TRD provided that peripheral agonism is rigorously avoided. Consistent with evolving scientific and regulatory safety frameworks, we propose advancing centrally selective, periphery\u2010sparing 5\u2010HT2BR antagonists into biomarker\u2010anchored early cardiac monitoring and preclinical exclusion of valve\u2010cell 5\u2010HT2BR agonism. This framework integrates central efficacy with defined safety boundaries, guiding development of mechanistically informed antidepressant therapies.<\/jats:p>","DOI":"10.1002\/cpt.70344","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:52:56Z","timestamp":1780023176000},"page":"345-356","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Serotonin\n                    <scp>2B<\/scp>\n                    (5\u2010\n                    <scp>HT2B<\/scp>\n                    ) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression"],"prefix":"10.1002","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6457-0086","authenticated-orcid":false,"given":"Gia Han","family":"Le","sequence":"first","affiliation":[{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto  Toronto Ontario Canada"},{"name":"Poul Hansen Family Centre for Depression, University Health Network  Toronto Ontario Canada"},{"name":"Brain and Cognition Discovery Foundation  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Wong","sequence":"additional","affiliation":[{"name":"Poul Hansen Family Centre for Depression, University Health Network  Toronto Ontario Canada"},{"name":"Brain and Cognition Discovery Foundation  Toronto Ontario Canada"},{"name":"Department of Pharmacology and Toxicology Faculty of Medicine, University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica E.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto  Toronto Ontario Canada"},{"name":"Poul Hansen Family Centre for Depression, University Health Network  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6641-0057","authenticated-orcid":false,"given":"Diana K.","family":"Orsini","sequence":"additional","affiliation":[{"name":"Poul Hansen Family Centre for Depression, University Health Network  Toronto Ontario Canada"},{"name":"Department of Pharmacology and Toxicology Faculty of Medicine, University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Jing","family":"Zheng","sequence":"additional","affiliation":[{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto  Toronto Ontario Canada"},{"name":"Brain and Cognition Discovery Foundation  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto  Toronto Ontario Canada"},{"name":"Poul Hansen Family Centre for Depression, University Health Network  Toronto Ontario Canada"},{"name":"Brain and Cognition Discovery Foundation  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Dri","sequence":"additional","affiliation":[{"name":"Brain and Cognition Discovery Foundation  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-2191","authenticated-orcid":false,"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto  Toronto Ontario Canada"},{"name":"Poul Hansen Family Centre for Depression, University Health Network  Toronto Ontario Canada"},{"name":"Department of Pharmacology and Toxicology Faculty of Medicine, University of Toronto  Toronto Ontario Canada"},{"name":"Department of Psychiatry University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"e_1_2_12_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115958"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-90"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21120"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2025.2500424"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852925000124"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01738-y"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.75.1.57"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.22063"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.10.015"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1139\/jpn.0427"},{"key":"e_1_2_12_12_1","first-page":"13","article-title":"Dopamine receptors: is it possible to become a therapeutic target for depression?","volume":"13","author":"Zhao F.","year":"2022","journal-title":"Front. Pharmacol."},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108687"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107401"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2011.03.005"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf0435"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1458612"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.159"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.03.008"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000081520.25714.D9"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2248883"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13249"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4771-x"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.14530"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20231063"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases11040159"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60252-X"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01178"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231190865"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-020-0723-y"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14020076"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00725-5"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)35225-5"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2013.12.004"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00225"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2490"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871529X17666170703115111"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2024.138013"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.07.014"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2009.05.002"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2016.662"},{"key":"e_1_2_12_43_1","first-page":"1140","article-title":"Drug\u2010associated valvular heart diseases and serotonin\u2010related pathways: a meta\u2010analysis","volume":"105","author":"Fortier J.H.","year":"2019","journal-title":"Heart Br. Card Soc."},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068265"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010128"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062222"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.23.2836"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.13.1703"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391101"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370901"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2044"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.03.010"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054830"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1384-23.2023"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118348"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-004-0951-4"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0005-8"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5723-07.2008"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.6.1223"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.06.045"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04252.x"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02565-4"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01336-3"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2017.12.014"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.3109\/08977194.2011.595714"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.050282397"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00205-y"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1306-5"},{"key":"e_1_2_12_69_1","article-title":"Chronic SSRI stimulation of astrocytic 5\u2010HT2B receptors change multiple gene expressions\/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift","volume":"9","author":"Hertz L.","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnint.2015.00067"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02269-8"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00388"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-020-00524-4"},{"key":"e_1_2_12_74_1","volume-title":"NDA 022529: Summary Review for Lorcaserin Hydrochloride (BELVIQ)","author":"U.S. Food and Drug Administration","year":"2012"},{"key":"e_1_2_12_75_1","volume-title":"FINTEPLA (Fenfluramine) Prescribing Information","author":"U.S. Food and Drug Administration","year":"2020"},{"key":"e_1_2_12_76_1","volume-title":"Psychedelic Drugs: Considerations for Clinical Investigations. Draft Guidance for Industry","author":"U.S. Food and Drug Administration","year":"2023"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-06783-7"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291722000745"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.160432"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000246"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12752"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10070"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22m14643"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220504"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.213793"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz040"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001034"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0278-3"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1017\/S109285292510045X"},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0604"},{"key":"e_1_2_12_91_1","article-title":"Efficacy of adjunctive aripiprazole in major depressive disorder: a pooled response quartile analysis and the predictive value of week 2 early response","volume":"14","author":"Casey D.E.","year":"2012","journal-title":"Prim. Care Companion CNS Disord."},{"key":"e_1_2_12_92_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2013.00102"},{"key":"e_1_2_12_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00146-7"},{"key":"e_1_2_12_94_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0207"},{"key":"e_1_2_12_95_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710000015"},{"key":"e_1_2_12_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00825-w"},{"key":"e_1_2_12_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104578"},{"key":"e_1_2_12_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40473-015-0044-3"},{"key":"e_1_2_12_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3381"},{"key":"e_1_2_12_100_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00006.2019"},{"key":"e_1_2_12_101_1","article-title":"Role of glycogenolysis in memory and learning: regulation by noradrenaline, serotonin and ATP","volume":"9","author":"Gibbs M.E.","year":"2015","journal-title":"Front. Integr. Neurosci."}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.70344","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:14:49Z","timestamp":1783912489000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.70344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1002\/cpt.70344"],"URL":"https:\/\/doi.org\/10.1002\/cpt.70344","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"2025-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}